S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

PMCB PharmaCyte Biotech Inc

1.57

0.00 (0.00%)

Pre Market

Last Updated: 06:00:00

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

PharmaCyte Biotech (NASDAQ:PMCB)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more PharmaCyte Biotech Charts.

PharmaCyte Biotech (NASDAQ:PMCB)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more PharmaCyte Biotech Charts.

PharmaCyte Biotech Inc News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 13 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 4 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 13 August 2024 (5 months ago) • Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Monday 29 July 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (6 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 30 May 2024 (7 months ago) • Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership
Thursday 30 May 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 23 May 2024 (7 months ago) • Edgar (US Regulatory)

More PharmaCyte Biotech Inc News Articles

Vontobel Financial Produ...

Kingdom of Belgium

Intesa Sanpaolo

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions